Cryoport Inc (CYRX) 6.7500 $CYRX
Cryoport Selected for Logistics Support of CaRE Arthritis Personalized Medicine Efforts
PR Newswire - Wed Jun 17, 7:30AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("Company"

, the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that the Company is the preferred cryogenic logistics provider to CaRE Arthritis ("CaRE"

.
Cryoport: A Niche Player That Doesn't Know It
Gains on Gains - at Seeking Alpha - Mon Jun 15, 3:00PM CDT
Cryoport Selected by Lynden International as the Preferred Cryogenic Logistics Provider
PR Newswire - Wed Jun 10, 7:30AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("Company"

, the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that it has been selected by Lynden International ("Lynden"

as its preferred provider to support cold chain clinical trial logistics for underrepresented diseases in Africa.
Cryoport Supports ArunA Biomedical's Cryogenic Shipments of Stem Cell Kits
PR Newswire - Wed Jun 03, 7:30AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("Company"

, the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that the Company is supporting ArunA Biomedical's ("ArunA"

cryogenic shipments of stem cell kits.
Cryoport achieves record revenue rise of 48% for fiscal 2015
M2 - Wed May 20, 6:25AM CDT
Cryogenic logistics company Cryoport (OTCBB:CYRX) disclosed on Tuesday that it recorded a net loss of USD12.2m (USD2.44 per common share) for the 12 month periods ended 31 March 2015.
Cryoport Reports Record Revenues For Fourth Quarter and Fiscal Year 2015
PR Newswire - Tue May 19, 7:30AM CDT
Cryoport, Inc. (OTCBB: CYRX) today announced financial results for the three and twelve-month periods ended March 31, 2015.
Cryoport to Present its FY2015 Results and Business Update at the 2015 Marcum MicroCap Conference
PR Newswire - Thu May 07, 7:30AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("Company"

, the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal husbandry and reproductive medicine, announced today that its Chief Executive Officer, Jerrell Shelton, is scheduled to present at the 2015 Marcum MicroCap Conference at the Grand Hyatt in New York City on Thursday, May 28, 2015 at 9:30 a.m. EDT.
Cryoport Supports NeoStem's Intus Study for the Treatment of Metastatic Melanoma
PR Newswire - Wed Apr 29, 7:30AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("Company"

, the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced that the Company is supporting NeoStem, Inc.'s (NASDAQ: NBS) Intus Study to evaluate its lead cancer immunotherapy, NBS20, for the treatment of metastatic melanoma.
NBS: 2.25 (-0.09)
Cryoport to Support the Equine Animal Husbandry Market Through Agreement with Yancey Farms
PR Newswire - Thu Apr 23, 8:15AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("Company"

, the leading provider of advanced cryogenic logistics solutions for the life sciences industry, today announced that the Company has further established its cryogenic logistics solutions within the animal husbandry market by signing a new customer agreement with Yancey Farms to support the shipment of equine semen for artificial insemination of top German Sport horse Stallions.
Cryoport to Present at the 3rd Annual BioLogistics Summit in San Francisco, CA
PR Newswire - Tue Apr 21, 7:30AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("Company"

, the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced that Dr. Mark W. Sawicki, Chief Commercial Officer, will present at the 3rd Annual BioLogistics Summit in San Francisco, CA on Wednesday, July 15th, 2015, at 2:15 p.m. PT. Dr. Sawicki will discuss advanced logistics for both clinical samples and commercial finished goods of emerging cell and gene therapies.
Cryoport Expands Logistics Support to Capricor's DYNAMIC Clinical Trial for Heart Failure
PR Newswire - Tue Apr 07, 7:30AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("Company"

, the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced that the Company has expanded its relationship with Capricor Therapeutics ("Capricor"

to provide a comprehensive cryogenic logistics solution to support both their ALLSTAR and DYNAMIC clinical trials.
CAPR: 4.70 (-0.06)
Cryoport has Been Engaged by Roslin Cells for Logistics Support of Roslin's iPSC service
PR Newswire - Tue Mar 31, 7:30AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("Company"

, the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that it has been engaged to provide its cryogenic logistics services to Roslin Cells of Edinburgh, United Kingdom in support of Roslin's induced pluripotent stem cell (iPSC) reprogramming service.
CombiMatrix Selects Cryoport as Logistics Partner for the Distribution of Its New Genetic Screening Service
PR Newswire - Tue Mar 24, 7:30AM CDT
CombiMatrix Corporation (NASDAQ: CBMX) and Cryoport, Inc. (OTCBB: CYRX), today announced CombiMatrix has selected Cryoport as its cryogenic logistics partner for the distribution of its new CombiPGS(TM) genetic screening test.
CBMX: 1.69 (+0.08)
Cryoport Introduces New Tamper-Proof Lock on its Cryoport Express(R) Shippers for Animal Husbandry
PR Newswire - Wed Mar 18, 7:30AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("Company"

, the leading provider of advanced cryogenic logistics solutions for the life sciences industry serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that the Company introduced Vet SecureSM, a new tamper-proof lock on its Cryoport Express® Shippers for exclusive use in the global animal husbandry market.
Cryoport Co-Sponsors the Alliance for Regenerative Medicine 3rd Annual REGENMED Investor Day
PR Newswire - Wed Mar 11, 7:30AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("Company"

, the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced that it is co-sponsoring the Alliance for Regenerative Medicine 3rd Annual REGENMED Investor Day, to be held March 25, 2015 at the Metropolitan Club in New York City.
Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division
PR Newswire - Tue Mar 03, 7:30AM CST
Cryoport, Inc. (OTCBB: CYRX) ("Company"

, the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced the expansion of its relationship with Fred Hutchinson Cancer Research Centers' ("Fred Hutch"

Clinical Research Division with the inclusion of additional labs to be supported by Cryoport's validated cryogenic logistics solutions for its cell-based therapies.
Cryoport Launches New Logistics Service Supporting Facility Relocation of Cryogenically Frozen Sample Collections
PR Newswire - Tue Feb 17, 7:30AM CST
Cryoport, Inc. (OTCBB: CYRX) ("Company"

, the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced the launch of a new logistics service supporting complete facility relocation of critical cryogenically frozen sample collections.
Cryoport Initiates Support of the Growing In-Vitro Fertilization Market in Nepal
PR Newswire - Tue Feb 10, 7:30AM CST
Cryoport, Inc. (OTCBB: CYRX) ("Company"

, the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, and reproductive medicine, today announced it has initiated support of the growing in-vitro fertilization ("IVF"

market in Nepal.
CryoPort's (CYRX) CEO Jerrell Shelton on Q3 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 05, 2:08PM CST
Cryoport EPS of -$0.03
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 7:36AM CST